PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

Biotech Stocks Healthcare Stocks
$14.86
+0.07 (+0.47%)
As of Aug 15, 2:29 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +54.8% upside
Low Target $15.62
Average Target $23.00
High Target $28.09
Current Price $14.86
Current
$14.86
Target
$23.00
$15.62 $23.00 avg $28.09
Scenario Analysis
Bear Case
$15.62
5.1%
Low target
Base Case
$23.00
+54.8%
Avg target
Bull Case
$28.09
+89.0%
High target
Risk/Reward
17.4x
Highly favorable
Price in Context
52-Week High
$27.40
-45.8% from high
52-Week Low
$6.27
+137.0% from low
Target vs 52W High
$23.00
-16.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%